AGP Executive Report
Last update: 10 hours agoDrug Access: China’s 2027 National Reimbursement Drug List will retain HUTCHMED’s ELUNATE, ORPATHYS and SULANDA, with expanded coverage for some cancer-treatment indications. AJOVY, a preventive migraine treatment, has also been added to the list, potentially reducing costs for eligible patients in mainland China. Macao Hospital Transport: During the Macau Grand Prix on Nov. 19–21, the shuttle serving Conde de São Januário General Hospital and Macao Union Medical Center will pick up passengers outside the China Dragon Hotel on Avenida da Praia Grande; the schedule is unchanged.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.